{
   "images" : {
      "b5d6ea53a3676027bfe9f69d41218917d20156da" : "https://static.dw.com/image/58016660_6.jpg"
   },
   "sources" : [
      {
         "month" : 7,
         "day" : "9",
         "name" : "DW",
         "year" : "2021",
         "permalink" : "https://www.dw.com/en/covid-cuba-approves-emergency-use-of-own-abdala-vaccine/a-58222105",
         "hash" : "b5d6ea53a3676027bfe9f69d41218917d20156da",
         "title" : "COVID: Cuba approves emergency use of own Abdala vaccine | DW | 09.07.2021"
      }
   ],
   "related" : [
      {
         "changes" : [],
         "keywords" : [
            "Abdala",
            "COVID-19 pandemic",
            "COVID-19 vaccine",
            "Cuba"
         ],
         "slug" : "/feed/2021/06/21/cuba-says-that-the-abdala-vaccine-is-proven-to-be-92-effective-against-covid-19",
         "score" : 4,
         "hash" : "31849d01cf4e0d99f10061f956011a4494854dbf",
         "text" : "Cuba says that the Abdala vaccine is proven to be 92% effective against COVID-19. ",
         "date" : "2021-06-21",
         "index" : 17
      },
      {
         "keywords" : [
            "Abdala",
            "COVID-19 pandemic",
            "Cuba"
         ],
         "changes" : [],
         "score" : 3,
         "slug" : "/feed/2021/06/14/cuba-expands-their-emergency-vaccination-plan-to-havana-and-other-parts-of-the-island-by-using-the-abdala-vaccine",
         "hash" : "4c2034325ee4d86464df7a5c1958b954a32dc486",
         "date" : "2021-06-14",
         "text" : "Cuba expands their emergency vaccination plan to Havana and other parts of the island by using the Abdala vaccine. ",
         "index" : 6
      },
      {
         "slug" : "/feed/2021/06/8/south-korea-reports-a-new-single-day-record-of-857000-doses-of-the-covid-19-vaccine-administered",
         "score" : 2,
         "date" : "2021-06-8",
         "index" : 12,
         "text" : "South Korea reports a new single-day record of 857,000 doses of the COVID-19 vaccine administered. ",
         "hash" : "f403267a930e9e96c04ad82bb7e21fded47f8ba8",
         "keywords" : [
            "COVID-19 pandemic",
            "COVID-19 vaccine"
         ],
         "changes" : []
      },
      {
         "score" : 2,
         "slug" : "/feed/2021/06/7/spain-reopens-its-international-borders-to-travellers-who-have-been-vaccinated-against-covid-19-for-tourists-from-low-r",
         "index" : 18,
         "hash" : "11204178dd57143672633e59be51d5d1c5ab7b6f",
         "date" : "2021-06-7",
         "text" : "Spain reopens its international borders to travellers who have been vaccinated against COVID-19. For tourists from low-risk countries, no proof of vaccination, recovery, or diagnostic test will be required and antigen tests are now accepted for travellers from risk zone countries. ",
         "changes" : [],
         "keywords" : [
            "COVID-19 pandemic",
            "COVID-19 vaccine"
         ]
      },
      {
         "keywords" : [
            "COVID-19 pandemic",
            "Caribbean",
            "Latin American"
         ],
         "changes" : [],
         "slug" : "/feed/2021/05/21/director-of-the-pan-american-health-organization-carissa-f-etienne-announces-that-latin-america-and-the-caribbean-have",
         "score" : 3,
         "text" : "Director of the Pan American Health Organization Carissa F. Etienne announces that Latin America and the Caribbean have surpassed one million deaths caused by COVID-19. ",
         "index" : 43,
         "hash" : "cbee84031702841827537418afb3d08f2aa3476a",
         "date" : "2021-05-21"
      },
      {
         "hash" : "c0638283bbed4979f93645208a26d1ddf722b373",
         "text" : "Cuba initiates its mass vaccination campaign for around 1.7 million people, using its locally-developed SOBERANA 02 and ABDALA vaccines, both of which have yet to complete its Phase III clinical trials. ",
         "date" : "2021-05-12",
         "index" : 40,
         "score" : 3,
         "slug" : "/feed/2021/05/12/cuba-initiates-its-mass-vaccination-campaign-for-around-17-million-people-using-its-locally-developed-soberana-02-and",
         "keywords" : [
            "COVID-19 pandemic",
            "COVID-19 vaccine",
            "Cuba"
         ],
         "changes" : []
      },
      {
         "slug" : "/feed/2021/05/12/kyrgyzstan-signs-a-agreement-with-the-world-bank-to-purchase-vaccines-developed-by-sinopharm",
         "score" : 2,
         "date" : "2021-05-12",
         "text" : "Kyrgyzstan signs a agreement with the World Bank to purchase vaccines developed by Sinopharm. ",
         "hash" : "44cc7015c64b90161902010239db2f64aa83f0b0",
         "index" : 20,
         "keywords" : [
            "COVID-19 pandemic",
            "COVID-19 vaccine"
         ],
         "changes" : []
      },
      {
         "keywords" : [
            "COVID-19 pandemic",
            "COVID-19 vaccine"
         ],
         "changes" : [
            {
               "timestamp" : 1612487111,
               "hash" : "8b84a42d9f51c0049c33e55c138acc14619c90a1",
               "text" : "The Ministry of Health grants emergency use authorization to China’s Sinopharm vaccine for use in Cambodia. ",
               "date" : "2021-02-4",
               "slug" : "/feed/2021/02/4/the-ministry-of-health-grants-emergency-use-authorization-to-china-s-sinopharm-vaccine-for-use-in-cambodia"
            }
         ],
         "slug" : "/feed/2021/02/4/the-ministry-of-health-grants-emergency-use-authorization-for-china-s-sinopharm-vaccine",
         "score" : 2,
         "hash" : "bc3c5f04c2670ded41cc733335c0dabc98b84d95",
         "date" : "2021-02-4",
         "index" : 16,
         "text" : "The Ministry of Health grants emergency use authorization for China's Sinopharm vaccine. "
      },
      {
         "slug" : "/feed/2021/01/23/chief-of-the-defence-staff-miguel-angel-villarroya-resigns-after-he-admitted-to-receiving-a-dose-of-the-covid-19-vaccine",
         "score" : 2,
         "text" : "Chief of the Defence Staff Miguel Ángel Villarroya resigns after he admitted to receiving a dose of the COVID-19 vaccine while not being on the priority list. ",
         "hash" : "c0f8a65759a7b97615a8f97400b04af9fc709f2d",
         "index" : 36,
         "date" : "2021-01-23",
         "keywords" : [
            "COVID-19 pandemic",
            "COVID-19 vaccine"
         ],
         "changes" : [
            {
               "slug" : "/feed/2021/01/23/spanish-chief-of-the-defence-staff-miguel-angel-villarroya-resigns-after-he-admitted-to-receiving-a-dose-of-the-covid-19",
               "date" : "2021-01-23",
               "text" : "Spanish Chief of the Defence Staff Miguel Ángel Villarroya resigns after he admitted to receiving a dose of the COVID-19 vaccine while not being on the priority list. ",
               "hash" : "ca95b68c893f8efc8f508060661786b05511eebe",
               "timestamp" : 1611500748
            }
         ]
      },
      {
         "changes" : [
            {
               "slug" : "/feed/2021/01/8/vaccine-developer-pfizer-announces-lab-studies-have-concluded-that-the-joint-pfizer-biontech-vaccine-remains-effective-a",
               "timestamp" : 1610154300,
               "hash" : "52baef8e5a2c4b0f88350b37a2645acdefff5853",
               "text" : "Vaccine developer Pfizer announces lab studies have concluded that the joint Pfizer–BioNTech vaccine remains effective against mutation variants of the SARS-CoV-2 virus, including Variant of Concern 202012-01 and the 501.V2 variant. ",
               "date" : "2021-01-8"
            }
         ],
         "keywords" : [
            "COVID-19 pandemic",
            "COVID-19 vaccine"
         ],
         "text" : "Vaccine developer Pfizer announces that lab studies have concluded that the joint Pfizer–BioNTech vaccine remains effective against mutation variants of the SARS-CoV-2 virus, including Variant of Concern 202012-01 and the 501.V2 variant. ",
         "date" : "2021-01-8",
         "hash" : "711fd829d69cf861a33cee7bfaa24d825dd1ea7c",
         "index" : 66,
         "slug" : "/feed/2021/01/8/vaccine-developer-pfizer-announces-that-lab-studies-have-concluded-that-the-joint-pfizer-biontech-vaccine-remains-effect",
         "score" : 2
      }
   ],
   "changes" : [],
   "image" : "https://static.dw.com/image/58016660_6.jpg",
   "keywords" : [
      {
         "index" : 14,
         "slug" : "/wiki/abdala%20(vaccine)",
         "name" : "Abdala"
      },
      {
         "slug" : "/wiki/covid-19%20pandemic",
         "name" : "COVID-19 pandemic",
         "index" : 1
      },
      {
         "name" : "COVID-19 vaccine",
         "slug" : "/wiki/covid-19%20vaccine",
         "index" : 37
      },
      {
         "index" : 71,
         "slug" : "/wiki/caribbean",
         "name" : "Caribbean"
      },
      {
         "name" : "Cuba",
         "slug" : "/wiki/cuba",
         "index" : 2
      },
      {
         "index" : 116,
         "slug" : "/wiki/latin%20america",
         "name" : "Latin American"
      }
   ],
   "subtext" : "Communist Cuba has become the first Latin American country to come up with a successful coronavirus vaccine.",
   "keywords_list" : [
      "Abdala",
      "COVID-19 pandemic",
      "COVID-19 vaccine",
      "Caribbean",
      "Cuba",
      "Latin American"
   ],
   "keywords_main" : "COVID-19 pandemic",
   "date" : "2021-07-9",
   "hash" : "df32cc27838574ddb92b26154010767e63e976ff",
   "index" : 43,
   "text" : "Cuban health regulator CECMED approves the emergency use of the domestically-produced vaccine Abdala, becoming the fifth COVID-19 vaccine to be approved in the country. Manufacturers last month claimed that the vaccine, which requires three shots, has a 92% effectiveness rate against the virus. This makes Cuba the first Caribbean and Latin American country to successfully develop its own variation of the vaccine. ",
   "slug" : "/feed/2021/07/9/cuban-health-regulator-cecmed-approves-the-emergency-use-of-the-domestically-produced-vaccine-abdala-becoming-the-fifth"
}